Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,357 | 11,779 | 12,557 | 8,923 | 13,039 |
| Marketable Securities | 7,187 | 23,261 | 23,339 | 36,301 | 48,536 |
| Receivables | 11,742 | 13,779 | 12,786 | 16,554 | 13,473 |
| Inventories | 22,853 | 24,321 | 25,212 | 24,796 | 22,988 |
| TOTAL | $66,212 | $76,732 | $76,861 | $89,512 | $101,829 |
| Non-Current Assets | |||||
| PPE Net | 6,920 | 7,203 | 7,546 | 8,164 | 8,964 |
| Investments And Advances | 0 | 0 | 3,399 | 3,496 | 0 |
| Intangibles | 32,107 | 32,821 | 33,534 | 34,248 | 34,961 |
| Other Non-Current Assets | 7,410 | 8,249 | 8,633 | 8,325 | 8,996 |
| TOTAL | $46,437 | $48,273 | $53,112 | $54,233 | $52,921 |
| Total Assets | $112,649 | $125,005 | $129,973 | $143,745 | $154,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 76,487 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 10,291 | 8,759 | 8,760 | 9,785 | 10,747 |
| Accrued Expenses | 11,572 | 10,848 | 9,368 | 13,170 | 12,462 |
| TOTAL | $108,082 | $29,444 | $27,993 | $32,738 | $33,193 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 76,182 | 75,902 | 75,684 | 75,469 |
| Deferred Revenues | 6,518 | 6,554 | 6,188 | 6,461 | 6,612 |
| Other Non-Current Liabilities | 6,918 | 7,899 | 8,461 | 9,292 | 9,728 |
| TOTAL | $10,456 | $87,966 | $88,347 | $88,758 | $88,834 |
| Total Liabilities | $118,538 | $117,410 | $116,340 | $121,496 | $122,027 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,875 | 49,816 | 49,563 | 49,499 | 49,386 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -301,088 | -285,436 | -277,237 | -266,704 | -253,555 |
| Other shareholders' equity | -1 | 7 | 8 | -12 | -16 |
| TOTAL | $-5,889 | $7,595 | $13,633 | $22,249 | $32,723 |
| Total Liabilities And Equity | $112,649 | $125,005 | $129,973 | $143,745 | $154,750 |